scispace - formally typeset
N

Nathalie E. Blachère

Researcher at Howard Hughes Medical Institute

Publications -  18
Citations -  1003

Nathalie E. Blachère is an academic researcher from Howard Hughes Medical Institute. The author has contributed to research in topics: Antigen & T cell. The author has an hindex of 11, co-authored 18 publications receiving 566 citations. Previous affiliations of Nathalie E. Blachère include Rockefeller University.

Papers
More filters
Journal ArticleDOI

Vaccine Breakthrough Infections with SARS-CoV-2 Variants.

TL;DR: In this paper, a cohort of 417 persons who had received the second dose of BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine at least 2 weeks previously, identified 2 women with vaccine breakthrough infection.
Journal ArticleDOI

FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor.

TL;DR: Results show that expression of FAP is a tumor suppressor that abrogates tumorigenicity through regulation of cell growth and survival throughregulation of caspases via the intrinsic pathway.
Journal ArticleDOI

ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity.

TL;DR: A critical role is uncovered for ZFP36 RBPs in restraining T cell expansion and effector functions, and ZFP 36 inhibition is suggested as a strategy to enhance immune-based therapies.
Journal ArticleDOI

cTag-PAPERCLIP Reveals Alternative Polyadenylation Promotes Cell-Type Specific Protein Diversity and Shifts Araf Isoforms with Microglia Activation

TL;DR: A new platform is described, cTag-PAPERCLIP, that generates APA profiles from single cell populations in intact tissues that requires no tissue dissociation and preserves transcripts in native states, and identifies a role of APA in switching Araf protein isoforms during microglia activation, impacting production of downstream inflammatory cytokines.
Journal ArticleDOI

High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.

TL;DR: This study was undertaken to determine whether rheumatoid arthritis antibodies preferentially bind PAD2‐ or PAD4‐citrullinated fibrinogen.